Detalhe da pesquisa
1.
From a recombinant key antigen to an accurate, affordable serological test: Lessons learnt from COVID-19 for future pandemics.
Biochem Eng J
; 186: 108537, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35874089
2.
Process intensification for the production of yellow fever virus-like particles as potential recombinant vaccine antigen.
Biotechnol Bioeng
; 118(9): 3581-3592, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34143442
3.
Hydrocyclones as cell retention device for CHO perfusion processes in single-use bioreactors.
Biotechnol Bioeng
; 117(7): 1915-1928, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32181883
4.
Evaluation of different IRES-mediated tricistronic plasmid designs for expression of an anti-PCSK9 biosimilar monoclonal antibody in CHO cells.
Biotechnol Lett
; 42(12): 2511-2522, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676798
5.
New cost-effective bioconversion process of palm kernel cake into bioinsecticides based on Beauveria bassiana and Isaria javanica.
Appl Microbiol Biotechnol
; 102(6): 2595-2606, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417198
6.
Intermediate purification of CHO-derived recombinant human Factor IX using hydrophobic interaction membrane-based chromatography and its comparison to a sulfated resin.
Electrophoresis
; 38(22-23): 2900-2908, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869668
7.
Investigations into, and development of, a lyophilized and formulated recombinant human factor IX produced from CHO cells.
Biotechnol Lett
; 39(8): 1109-1120, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28484912
8.
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
Res Sq
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464059
9.
Conformational stability of SARS-CoV-2 glycoprotein spike variants.
iScience
; 26(1): 105696, 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36465857
10.
High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
PLoS One
; 18(4): e0283983, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018291
11.
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection.
Sci Rep
; 13(1): 18606, 2023 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903875
12.
Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 Infection.
Vaccines (Basel)
; 11(11)2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006064
13.
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Front Immunol
; 13: 918896, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35757764
14.
Functional Profiling of Antibody Immune Repertoires in Convalescent Zika Virus Disease Patients.
Front Immunol
; 12: 615102, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33732238
15.
The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to self.
J Exp Med
; 218(9)2021 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34292314
16.
Polyclonal F(ab')2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency.
iScience
; 24(11): 103315, 2021 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34723156
17.
Effect of Convalescent Plasma in Critically Ill Patients With COVID-19: An Observational Study.
Front Med (Lausanne)
; 8: 630982, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33585529
18.
Perfusion process combining low temperature and valeric acid for enhanced recombinant factor VIII production.
Biotechnol Prog
; 36(1): e2915, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587517
19.
Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
Vaccine
; 37(47): 6970-6977, 2019 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31164305
20.
Purification of flavivirus VLPs by a two-step chomatographic process.
Vaccine
; 37(47): 7061-7069, 2019 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31201056